Characterizing the Mechanisms of Nonopsonic Uptake of Cryptococci by Macrophages by Lim, Jenson et al.
of May 1, 2018.
This information is current as
Macrophages
Nonopsonic Uptake of Cryptococci by 
Characterizing the Mechanisms of
Rebecca A. Hall and Robin C. May
Camille L. Macleod, Claire J. Escaron, Gordon D. Brown,
Garelnabi, Leanne M. Taylor-Smith, Pauline Monteith, 
Jenson Lim, Christopher J. Coates, Paula I. Seoane, Mariam
ol.1700790
http://www.jimmunol.org/content/early/2018/04/10/jimmun
 published online 11 April 2018J Immunol 
        average*
   
 4 weeks from acceptance to publicationFast Publication! •  
   
 Every submission reviewed by practicing scientistsNo Triage! •  
   
 from submission to initial decisionRapid Reviews! 30 days* •  
   
Submit online. ?The JIWhy 
Subscription
http://jimmunol.org/subscription
 is online at: The Journal of ImmunologyInformation about subscribing to 
Permissions
http://www.aai.org/About/Publications/JI/copyright.html
Submit copyright permission requests at: 
Author Choice
 Author Choice option
The Journal of ImmunologyFreely available online through 
Email Alerts
http://jimmunol.org/alerts
Receive free email-alerts when new articles cite this article. Sign up at: 
Print ISSN: 0022-1767 Online ISSN: 1550-6606. 
Copyright © 2018 The Authors All rights reserved.
1451 Rockville Pike, Suite 650, Rockville, MD 20852
The American Association of Immunologists, Inc.,
 is published twice each month byThe Journal of Immunology
 by guest on M
ay 1, 2018
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
 by guest on M
ay 1, 2018
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
The Journal of Immunology
Characterizing the Mechanisms of Nonopsonic Uptake of
Cryptococci by Macrophages
Jenson Lim,* Christopher J. Coates,† Paula I. Seoane,‡ Mariam Garelnabi,‡
Leanne M. Taylor-Smith,‡ Pauline Monteith,* Camille L. Macleod,* Claire J. Escaron,x
Gordon D. Brown,{ Rebecca A. Hall,‡ and Robin C. May‡
The pathogenic fungus Cryptococcus enters the human host via inhalation into the lung and is able to reside in a niche environment
that is serum- (opsonin) limiting. Little is known about the mechanism by which nonopsonic phagocytosis occurs via phagocytes in
such situations. Using a combination of soluble inhibitors of phagocytic receptors and macrophages derived from knockout mice
and human volunteers, we show that uptake of nonopsonized Cryptococcus neoformans and C. gattii via the mannose receptor is
dependent on macrophage activation by cytokines. However, although uptake of C. neoformans is via both dectin-1 and dectin-2,
C. gattii uptake occurs largely via dectin-1. Interestingly, dectin inhibitors also blocked phagocytosis of unopsonized Cryptococci
in wax moth (Galleria mellonella) larvae and partially protected the larvae from infection by both fungi, supporting a key role
for host phagocytes in augmenting early disease establishment. Finally, we demonstrated that internalization of nonopsonized
Cryptococci is not accompanied by the nuclear translocation of NF-kB or its concomitant production of proinflammatory
cytokines such as TNF-a. Thus, nonopsonized Cryptococci are recognized by mammalian phagocytes in a manner that
minimizes proinflammatory cytokine production and potentially facilitates fungal pathogenesis. The Journal of Immunology,
2018, 200: 000–000.
C
ryptococcus neoformans and C. gattii are encapsulated
human fungal pathogens that cause cryptococcosis
in immunocompromised and, more rarely, immuno-
competent individuals. Often found as free-living cells in soil
and avian excreta, Cryptococci are not intrinsic human path-
ogens. However, Cryptococci become human pathogens be-
cause several defense mechanisms possessed by these fungi
also act as virulence factors within a human or animal host (1),
including the ability, firstly, to survive and replicate within
free-living soil amoeba and, secondly, to evade clearance by
the host immune system by hiding and persisting within
macrophages (2, 3).
As Cryptococci enter hosts via inhalation into the lungs, they
are detected and phagocytosed by resident alveolar macrophages
(4). Phagocytosis is a multistep process that sequentially in-
volves receptor-mediated particle recognition, actin-driven up-
take, phagosome maturation, and particle clearance. It is critical
during the early innate immune response to ensure the removal
of microorganisms and apoptotic cells as well as subsequent
priming of the adaptive immune response through the produc-
tion and release of cytokines, such as TNF-a (5). Phagocytosis
of Cryptococci is typically inefficient unless they are opsonized
(coated) by Abs or complement proteins found in serum within the
circulatory system. Interestingly, there is a lack of serum opsonins
in the alveoli of the lungs, and so the initial uptake of Cryptococcus
upon colonization is most likely through a nonopsonized route (6).
Nonopsonic phagocytosis requires host cell phagocytic pattern
recognition receptors (PRRs) to directly recognize fungal cell
wall components (pathogen-associated molecular patterns
[PAMPs]) (7) such as b-glucans or mannan polysaccharides, but
the nature of this interaction for Cryptococci remains unknown. In
this article, we show that nonopsonized C. neoformans and
C. gattii enter macrophages in a spleen tyrosine kinase (Syk)–
dependent, mannose receptor–independent manner that involves
the receptors Dectin-1 and Dectin-2. This differential uptake of C.
neoformans and C. gattii corresponds to differential exposure of
PAMPs found on the fungal cell wall. Phagocytic kinetics of
macrophages and insect hemocytes in the absence or presence of
cellular receptor inhibitors were similar in response to fungal
targets. Finally, we demonstrate that entry of Cryptococcus does
not affect NF-kB nuclear translocation or subsequent TNF-a re-
lease, highlighting the remarkably noninflammatory capabilities
of this organism.
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Materials and Methods
Reagents
All reagents (e.g., heat-inactivated FBS, DMEM, L-glutamine, powdered yeast-
extract peptone dextrose, and PBS) were purchased from Sigma-Aldrich unless
stated otherwise. Mouse macrophage–CSF (130-094-129) and human GM-
CSF (130-093-862) were purchased from Miltenyi Biotec. Commercially
sourced inhibitors tested included the Syk–inhibiting plant metabolite,
Piceatannol (527948; Calbiochem); the b-1,3-glucan from brown algae
Laminaria digitata, Laminarin (L9634; Sigma-Aldrich); and mannan from
Saccharomyces cerevisiae (M7504; Sigma-Aldrich).
The Abs used in this study were rabbit anti-sheep RBCs, IgG fraction
(#55806; MP Biomedicals); rabbit anti-sheep RBCs, IgM fraction
(CL9000M; VH Bio/Cedarlane); rabbit anti–65 kDa subunit (p65) NF-kB
mAb (clone D14E12, #8242; New England Biolabs/Cell Signaling Tech-
nology); rat anti-aM (clone 5c6, MCA2289; Bio-Rad AbD Serotec); and
rabbit anti–Phospho-Syk (Tyr525/526 in humans, Tyr519/520 in mice,
clone C87C1, #2710; New England Biolabs/Cell Signaling Technology),
a kind gift from Y. Senis (University of Birmingham). Rhodamine-
Phalloidin and Alexa Fluor–conjugated secondary Abs were purchased
from Life Technologies and Calcofluor White from Sigma-Aldrich.
Glucan-6-phosphate and mouse anti-cryptococcal capsule Ab (clone
18B7) were kind gifts from D. Williams (East Tennessee State University)
and A. Casadevall (Albert Einstein College of Medicine), respectively.
Mice
Mice devoid of specific PRRs (in C57BL/6 background) were reported
previously (8, 9) and were housed under pathogen-free conditions in the
registered animal facility at the University of Aberdeen. Mice were allo-
cated to experimental groups on the basis of genotype and age-matching.
All animal procedures were performed according to the protocols provided
by the Animal Welfare and Ethical Review Body of the University of
Aberdeen and are regulated by the UK Home Office Animal (Scientific
Procedures) Act of 1986 and European Directive 2010/63/EU.
Yeast and bacterial cell growth conditions
C. neoformans strain H99, C. gattii strain R265, and Candida albicans
strain SC5314 were incubated in liquid yeast-extract peptone dextrose
medium for 24 h (unless stated otherwise) at 25˚C on a rotator at 20 rpm (or
37˚C, 200 rpm for C. albicans). Escherichia coli strain DH5a was incubated
in Luria-Bertani broth for 16 h at 37˚C in a shaking incubator at 200 rpm.
Yeast cells were centrifuged at 30003 g for 2.5 min (or 6000 3 g for 1 min
for E. coli), washed three times in PBS, and counted with a hemocytometer
prior to use.
Mammalian cell growth conditions
Cells from the murine macrophage–like cell line J774.A1 (American Type
Culture Collection number TIB-67) were cultured in DMEM supple-
mented with 2 mM L-glutamine and 10% heat-inactivated FBS at 37˚C, 5%
CO2 (10). As required, macrophages were scrapped in PBS, counted, and
seeded (50,000/well) onto 13 mm acid-washed glass coverslips, and in-
cubated for 24 h at 37˚C, 5% CO2 prior to experimental use.
Macrophages devoid of specific PRRs were derived from mouse bone
marrow. Bone marrows were flushed using a 21-gauge needle from the hind
leg bones of either receptor knockout (KO) or litter-matched wild type (WT)
mice. Monocytes were differentiated into macrophages with 20 ng/ml M-
CSF (Miltenyi Biotec) for 7 d.
Pooled PBMCs were isolated from whole blood from healthy volunteers
using density gradient centrifugation with Ficoll-Paque (GE Healthcare).
The mononuclear layer was collected and washed with PBS to remove
platelets. Monocytes were purified by adherence to plastic in RPMI 1640
media supplemented with 5% heat-inactivated FBS, 2 mM glutamine,
100 mg/ml streptomycin, and 100 U/ml penicillin at 37˚C, 5% CO2 for 1 h.
Nonadherent cells were removed with PBS and adherent cells differenti-
ated into macrophages with 20 ng/ml recombinant human GM-CSF
(Miltenyi Biotec) for 7 d. This study was covered by the University of
Birmingham’s Science, Technology, Engineering, and Mathematics Ethi-
cal Review Committee.
Phagocytic challenge
Macrophages were serum starved for 2–16 h with serum-free medium
at 37˚C, 5% CO2. Where needed, inhibitors were added directly and
left for a further 30 min. Next, media were removed prior to fresh
serum-free medium being added containing either 1 mg/ml 18B7 Ab
(against cryptococcal capsule) or unopsonized targets at a multiplicity
of infection of either 10:1 or 20:1 for 20–180 min at 37˚C, 5% CO2.
Cells were washed three times with PBS to remove unbound yeast/
bacteria cells and fixed in 4% paraformaldehyde for 10 min at room
temperature (RT).
Galleria mellonella maintenance
Larvae of the greater wax moth, Galleria mellonella, were sourced from
Livefoods Direct (U.K.) and stored in wood shavings in the dark at 13˚C.
This study was covered by the University of Stirling’s Animal Welfare and
Ethical Review Body. Healthy larvae weighing between 0.2 and 0.4 g were
used in all experiments. Larvae were inoculated with different concen-
trations of inhibitors via intrahemocele injection 1 h prior to infection with
1 million C. neoformans H99 per larva as described previously (11).
Controls consisted of larvae that received a 20 ml PBS inoculum. Three to
five larvae were used per treatment, with all treatments being performed on
at least three independent occasions.
For phagocytosis, larvae were bled and hemolymph treated as previously
described (12). Briefly, pooled hemolymph was mixed with 0.5 ml PBS
and added onto a 13 mm coverslip in a 24-well plate. Hemocytes were
centrifuged onto the coverslips for 10 min at 5003 g at RT before washing
three times with PBS to remove noninternalized yeasts. Cells were then
fixed with 4% paraformaldehyde before permeabilization and immunos-
tained as described below. All determinations were performed on at least
three independent occasions.
Immunofluorescence and scoring
Fixed cells on coverslips were permeabilized with 0.1% Triton X-100 for
5 min (if necessary to identify internalized yeasts), washed with PBS, and
blocked with 0.5% BSA in PBS for 30 min. Appropriate primary Abs
(1:200 dilution) were added to cells, left for 30 min at RT, washed with
PBS, and counterstained with the appropriate fluorophore–conjugated
secondary Ab, along with Rhodamine-Phalloidin and Calcofluor White.
Coverslips were then washed in PBS and distilled water before mounted
in ProLong Gold Antifade Reagent (Life Technologies) and analyzed by
microscopy.
For counting of phagocytosed yeast/bacteria, fixed but unpermeabilized
cells on coverslips were stained with Calcofluor White to highlight the
external yeasts. Coverslips were analyzed with a Nikon Eclipse Ti mi-
croscope under a 633 oil immersion objective. Between 5 and 10 fields of
view of each coverslip were counted for number of macrophages and as-
sociation of microbial cells. At least 100 macrophages were observed for
each coverslip.
The enrichment in phosphorylated Syk at sites of yeast binding and the
translocation of p65 into the nucleus during NF-kB activation were
studied and scored by the Nikon A1R confocal microscope using 203 to
633 objectives. For the former, a minimum of 25 infected cells per
condition were analyzed for a discrete local enrichment in marker signal
(Syk) at bound particles. For the latter, between three and five fields of
view for each sample/coverslip were counted for the number of macro-
phages with p65 marker signal located within the nucleus and expressed
as a percentage of the total number of macrophages (%NF-kB nuclear
translocation).
In vitro cytokine production
J774.A1 and primary human macrophages were cultured in 96-well
microtiter plates (Greiner) at 10,000 cells/well in a final volume of 200 ml.
Cells were stimulated with either control medium, LPS, or a range of
unopsonized pathogenic yeasts. After 6 h of incubation at 37˚C, plates
were centrifuged (500 3 g for 10 min), and the supernatant was collected
and stored at280˚C until cytokine assays were performed. Levels of TNF-
a were determined by commercial ELISA kits, used according to the in-
structions of the manufacturer (R&D Systems).
Statistical analyses
Analysis carried out on the results described in this paper was by a gen-
eralized linear model using a Poisson error distribution in R (R Devel-
opment Core Team). This was tested for significance using a post hoc Tukey
honest significant difference (HSD) test.
Results
Uptake of nonopsonized Cryptococci via mannose receptor is
activation dependent
As previously observed, the levels of nonopsonic uptake of
Cryptococci is very low (e.g., 0.4% of C. neoformans serotype
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D was taken up by unstimulated mouse peritoneal macro-
phages; or 7–21% of C. gattii R265 was taken up by human
dendritic cells (DCs); (13, 14)) and our results are in agree-
ment with those findings – 8.89 or 5.83% of primary human
macrophages contained one or more C. neoformans H99 or C.
gattii R265, respectively (based on the carrier controls in
Figs. 1C, 2B), after 2 h of incubation. The mannose receptor is
broadly expressed on macrophages and important for the
nonopsonic uptake of fungal pathogens such as C. albicans
and Pneumocystis carinii (15, 16). The uptake of C. neofor-
mans H99 or C. gattii R265 by J774.A1 macrophages
pretreated with soluble mannan (a competitive inhibitor of
mannose receptor binding) was unaltered relative to control
(untreated) cells (Fig. 1A). Similarly, M-CSF differentiated
bone marrow macrophages (BMMs) from mannose receptor
KO mice (MR KO) showed no reduction in uptake of either
C. neoformans or C. gattii relative to WT control cells
(Fig. 1B). Interestingly, however, GM-CSF–differentiated
primary human macrophages showed a strong inhibition of up-
take under the same conditions (Fig. 1C), suggesting that the
mannose receptor may play a greater role in cryptococcal uptake
into human cells than those of mice.
Phagocytosis of unopsonized Cryptococci is Syk-dependent
The other major class of nonopsonic phagocytic receptors for
fungi are the dectins (17). Both dectin-1 and dectin-2 require
Syk activity for their function, via ITAMs contained within
dectin-1 itself or via membrane association with ITAM–
containing Fc receptor g-chain in the case of dectin-2
(18). Inhibiting Syk activity in J774.A1 cells by using picea-
tannol (19) resulted in a marked reduction in their ability to
phagocytose either C. neoformans H99 or C. gattii R265 (Fig. 2A,
p , 0.05). The same observation was also seen in GM-CSF–dif-
ferentiated primary human macrophages from pooled monocytes
isolated from human volunteers (Fig. 2B). In line with this,
staining with an anti–Phospho-Syk Ab showed intense ac-
cumulation of active Syk at phagocytic cups forming around
nonopsonized Cryptococci (Fig. 3). This Ab was raised
against the tyrosine phosphorylated residues at positions 525
and 526, located in the activation loop of the Syk kinase
domain and essential for Syk function (20). Therefore, we
propose that the localization of this Ab to the sites of non-
opsonic uptake of Cryptococci and the activity of picea-
tannol in blocking uptake suggests that Syk activity is
required for internalization.
Phagocytosis of unopsonized Cryptococci is partially
dependent on Dectin-1
To test for a role for the dectin family of receptors during
phagocytic uptake of nonopsonized Cryptococci, we first ex-
posed J774.A1 macrophages (Fig. 4A) or differentiated pri-
mary human macrophages (Fig. 4B) to the dectin-1 inhibitor
glucan-6-phosphate before challenging with either unopson-
ized C. gattii R265 or C. neoformans H99. This inhibitor
FIGURE 1. Mannose receptor is important but dis-
pensable during uptake of Cryptococcus particles.
Mouse macrophage cell line J774.A1 (A) or differenti-
ated BMMs (B) (WT or MR KO) or differentiated pri-
mary human macrophages (C) were challenged with
either C. neoformans H99 (Cn, black bars) or C. gattii
R265 (Cg, white bars) for 60 min, processed for im-
munofluorescence, and scored for phagocytosis as
described in Materials and Methods. Where indi-
cated, J774.A1 and primary human macrophages were
pretreated with 100 mg/ml mannan (MAN) for 30 min
before the addition of Cryptococcus particles. Phago-
cytosis indices were related to the values obtained from
the negative controls. Number in bars indicate the total
number of phagocytes counted. Results are expressed as
the mean 6 SD of at least three independent experi-
ments.
FIGURE 2. Uptake of Cryptococcus particles is
Syk-dependent. Mouse macrophage cell line J774.
A1 (A) or differentiated primary human macro-
phages (B) were challenged with unopsonized
C. neoformans H99 (Cn, black bars) or C. gattii
R265 (Cg, white bars) for 60 min, processed for
immunofluorescence, and scored for phagocytosis
as described in Materials and Methods. Phagocy-
tosis indices were related to the values obtained
from the negative controls. Number in bars indicate
the total number of phagocytes counted. Results are
expressed as the mean 6 SD of at least three in-
dependent experiments.
The Journal of Immunology 3
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partially blocked the uptake of both species of Cryptococcus,
suggesting dectin-1 contributes toward Cryptococci uptake but is
not the sole recognition receptor involved in this process
(Fig. 4A, 4B). In line with this, M-CSF–differentiated BMMs
from dectin-1 and dectin-2 KO mice both showed substantially
impaired uptake of C. neoformans H99 – surprisingly, this was
not the case for C. gattii R265 (Fig. 4C). This suggests either the
presence of another Syk-dependent nonopsonic receptor or that
both dectins are redundant with each other for C. gattii, but not
C. neoformans uptake.
Nonopsonic uptake in the Galleria model
The greater wax moth, G. mellonella, is widely used as a model
organism in the study of host–pathogen interactions with a variety
of human pathogens (21). As with other insects, G. mellonella
does not possess an adaptive immune system like mammals but
possesses a complex innate immune system that includes phago-
cytic cells, termed hemocytes (22, 23). We therefore tested
whether nonopsonic uptake of Cryptococci in G. mellonella
showed similar receptor dependency as in mammalian cells by
pretreating larvae for 1 h with soluble mannan, glucan-6-phosphate,
FIGURE 3. Activated Syk is essential for
the uptake of Cryptococcus particles. Mouse
macrophage cell line J774.A1 was chal-
lenged with either (IgG-opsonized or
unopsonized, U/O) C. neoformans H99 or C.
gattii R265 for 15 min (B), processed for
immunofluorescence, and analyzed by con-
focal microscopy of localized phospho-Syk
(B and C) as described in Materials and
Methods. (A) Schematic diagram J774.A1
macrophage with intracellular actin cyto-
skeleton (red) and yeast particles (blue). To
confirm phospho-Syk localization, the bot-
tom of the cells was observed first [(A), grey
dashed line and (B), bottom panels], before
moving to the middle of the cells [(A), purple
dashed line, (B), top panels]. Pixel intensities
for 20 cells per sample were determined [(C),
right] and normalized to the intensity at the
center of the cell [(C), left]. (A and C) The
green triangles denote phospho-Syk. The
black line denotes the outline of a cell as
imagined from the side (i.e., its z-axis). Re-
sults are expressed as the mean 6 SD of at
least three independent experiments. Scale
bar, 20 mm.
FIGURE 4. Dectins are required for
uptake of Cryptococcus particles. Mouse
macrophage cell line J774.A1 (A), differ-
entiated primary human macrophages (B),
or differentiated BMMs (C) (WT, Dectin-1
KO, or Dectin-2 KO) were challenged
with either C. neoformans H99 (Cn, black
bars) or C. gattii R265 (Cg, white bars) for
60 min, processed for immunofluores-
cence, and scored for phagocytosis as de-
scribed in Materials and Methods. Where
indicated, J774.A1 were pretreated with
100 mg/ml glucan-6-phosphate (G6P) for
30 min before the addition of Cryptococ-
cus particles. Phagocytosis indices were
related to the values obtained from the
negative controls. Number in bars indicate
the total number of phagocytes counted.
Results are expressed as the mean 6 SD
of at least three independent experiments.
*p , 0.05. ns, not significant (p $ 0.05).
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or laminarin. The full genome sequence of Galleria is currently
available but not fully annotated (24). However, several b-1,3-
glucan–binding protein analogs and C-type lectins have been
characterized in this species, as well as other Lepidopterans,
namely Manduca sexta (25, 26), Bombyx mori (27), and Plodia
interpunctella (28). Recognition of fungal PAMPs (e.g., curdlan
and mannan) by membrane-bound receptors modulate cellular
(hemocyte)-directed immunity in insects (encapsulation, nodula-
tion, and phagocytosis) (29). Although soluble mannan did not
significantly reduce association of Cryptococci with Galleria
hemocytes in data presented in this paper, both glucan-6-
phosphate and laminarin led to a marked reduction in uptake
(Fig. 5, p , 0.001 for both when compared to the PBS controls).
Interestingly, administering glucan-6-phosphate or laminarin for
24 h appeared to partially protect the insect larvae from infection by
both unopsonized species of Cryptococcus (Fig. 6), suggesting that
disease establishment in this model organism requires the fungus
to grow intracellularly, something that has previously been pro-
posed for human hosts (30).
Cryptococcal uptake by macrophages does not lead to
increased proinflammatory cytokine secretion
Unlike many pathogens, internalization of opsonized Cryptococci
into phagocytes is not accompanied by the production of proin-
flammatory cytokines such as TNF and IL-1a or IL-1b (31, 32). To
test whether this is also true of nonopsonic uptake, we measured
the secretion of TNF-a and nuclear translocation of p65 (a major
regulator of cytokine transcription) from J774.A1 macrophages upon
challenge with unopsonized or serum-opsonized C. neoformans H99
or C. gattii R265. Although LPS-stimulated macrophages showed
strong nuclear translocation of p65, neither IgG-opsonized nor
unopsonized C. neoformans H99 or C. gattii R265 stimulated NF-kB
activation (Fig. 7A). However, NF-kB activation could be restored in
cryptococcal exposed macrophages by the subsequent addition of
LPS (Fig. 7B).
Furthermore, to test whether internalization of unopsonized
Cryptococci into J774.A1 mouse macrophages or primary human
macrophages elicits the production of proinflammatory cytokines
such as TNF, we measured the secretion of TNF-a from J774.A1
macrophages or primary human macrophages upon challenge with
unopsonized C. neoformans H99 or C. gattii R265, with C. albi-
cans and LPS as controls. With J774.A1 mouse macrophage and
primary human macrophages, C. albicans- or LPS-stimulated
macrophages showed stronger TNF-a production compared to
varying doses of C. neoformans H99 or C. gattii R265 (Fig. 8;
p = 0.04 for C. albicans versus media control, p . 0.05 for C.
albicans versus C. neoformans/C. gattii). Overall, this suggests
that Cryptococci do not actively block inflammatory signaling in
host cells and do not induce a strong inflammatory stimulus fol-
lowing nonopsonic uptake.
Discussion
In this study, we examined the phagocytic uptake of unopsonized
cryptococcal yeast particles by macrophages. This process relies on
the use of phagocytic receptors, which can be categorized either as
opsonic or nonopsonic. Opsonic phagocytic receptors include the
Fc receptor and complement receptor families, which recognize
Ab- or complement-opsonized (coated) particles, respectively.
Nonopsonic phagocytic receptors are PRRs, such as the C-type
lectin family of receptors, which recognize distinct PAMPs on
the fungal surface (33).
Although phagocytosis of Cryptococcus within the circulatory
system would occur predominantly through an opsonized (coated)
uptake route because of the presence of Abs and/or complement
proteins found in serum, this is not always the case. For example,
the first encounter of the human body with Cryptococcus is
through the lungs when desiccated yeast cells or spores are
breathed in. These cryptococcal particles encounter their initial
immunological challenge through resident alveolar macrophages
and DCs in a serum-deficient or low-serum environment (34–36).
Interestingly, it was reported recently that between 25 and 40%
of mouse lung-resident macrophages are able to phagocytose
C. neoformans particles through a scavenger receptor pathway
(37). Therefore, this confirms that initial uptake of Cryptococcus
FIGURE 5. Administration of polysaccharides blocks uptake of Cryp-
tococcus particles to hemocytes in the G. mellonella larvae model. Larvae
were inoculated with 60 mg of blocking sugars 1 h prior to infection for 2 h
with 106 C. neoformans H99 (black bars) or C. gattii R265 (white bars).
Uptake of yeast of hemocytes was determined under light microscopy.
Results are expressed as the mean 6 SD of at least three inde-
pendent experiments. *p , 0.05 (related to PBS control). ns, not
significant (p $ 0.05).
FIGURE 6. Glucan administration protects G. mellonella larvae from
infection by C. neoformans or C. gattii. Larvae were inoculated with 60 mg
of blocking sugars 24 h prior to infection for a further 24 h with 106
C. neoformans H99 (black bars) or C. gattii R265 (white bars). Fungal load
was determined by serially diluting homogenized larvae and plating ali-
quots onto erythromycin containing agar plates. Yeast cell density were
related to the values obtained from the negative (PBS) controls and
expressed as cfu3 105/larva. Results are expressed as the mean6 SD of at
least three independent experiments. *p , 0.05 (related to PBS control).
ns, not significant (p $ 0.05).
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by macrophages is most likely through a nonopsonized route, and
there is a need to understand the mechanisms that underpin this
process (6). We confirmed that, compared with the bacterium
E. coli or fungus C. albicans, Cryptococci cells are not readily
taken up by mammalian macrophages, most likely because of
the presence of the capsule, which renders Cryptococci anti-
phagocytic (38, 39). By using a combination of a soluble mannose
inhibitor and MR KO tissue, we demonstrated that mannose re-
ceptor was not necessary for the uptake of either species of
Cryptococcus, in line with recent data from the zebrafish model
(40), although this is not the case in primary human macrophages.
We note that others have shown MR KO mice to be more sus-
ceptible to C. neoformans (41) and demonstrated a role for this
receptor, along with FcgRII (CD32) in driving cryptococcal up-
take into DCs (42). Thus, mannose receptor dependency appar-
ently varies across different cell types and tissue contexts.
Next, we pursued a different set of nonopsonic PRRs, dectin-1
and dectin-2, which are C-type lectin receptors that are highly
expressed in macrophages and are key b-glucan receptors (43, 44).
Recognition of soluble or surface expressed b-glucans on yeasts
is sufficient to initiate and mediate phagocytosis and proin-
flammatory cytokine responses (45). Both of these receptors re-
quire Syk activity (18, 46, 47), and, indeed, our data clearly
demonstrate the activation of Syk at phagocytic cups containing
unopsonized Cryptococci, as well as a strong dependency on Syk
for particle uptake. Interestingly, pharmacological inhibition of
dectins inhibited uptake of both C. neoformans and C. gattii in
J774.A1 mouse and human macrophages, but BMMs from dectin-
1– and dectin-2–KO mice showed defects only in the uptake of
C. neoformans and not C. gattii, an effect that has been observed
before (48). The most parsimonious explanation is therefore that
the two dectin receptors are redundant for the uptake of C. gattii,
but not C. neoformans, perhaps reflecting differing surface com-
ponents between the two species, as reported recently (49). Such
surface variation between species, strains, and potentially devel-
opmental stages of Cryptococci may explain many of the previous
inconsistencies in the literature regarding dectin dependency
(or otherwise) (50, 51).
Alongside mouse macrophages, we adopted wax worm
larvae (G. mellonella) as an alternative model for understanding
cryptococcal virulence and host immune responses (52–54) in
which cryptococcal phagocytosis has previously been reported
(55). Our data demonstrate striking similarities in patterns of
uptake between this invertebrate host and murine phagocytes. In
addition, we showed that inhibiting phagocytosis in this alterna-
tive host reduces disease burden, highlighting the importance of
host phagocytes as a niche for cryptococcal replication.
We acknowledge that although there are currently no direct
dectin receptor homologs identified in G. mellonella, many C-type
lectins have been characterized in other insect models, for ex-
ample; the tobacco hornworm, Manduca sexta (immulectin-2 fa-
cilitates phagocytosis of bacteria (56)); webworm, Hyphantria
cunea (lectin (57, 58)); silkworm, Bombyx mori (BmLBP and
BmMBP (59, 60)); and the cockroach, Blaberus discoidalis
(a b-glucan–specific lectin (61)). These invertebrate C-type lectins
FIGURE 7. Uptake of Cryptococcus did not affect
NF-kB nuclear translocation. J774.A1 macrophages
were challenged with a variety of opsonized or
unopsonized pathogenic fungi, SRBCs, or soluble ago-
nists (LPS or PMA), processed for immunofluores-
cences, analyzed by microscopy (A), and scored for p65
nuclear translocation (B), as described in Materials and
Methods. (A) Representative images of PMA- (top) or
LPS- (bottom) stimulated J774.A1 macrophages and
stained to highlight either actin or p65. Actin was
stained using rhodamine-phalloidin; p65 was stained
using the anti–65 kDa subunit (p65) NFkB mAb with an
anti-rabbit Alexa Fluor–488. Scale bar, 20 mm.
FIGURE 8. Uptake of Cryptococcus did not affect proinflammatory
cytokine response. J774.A1 macrophages (black bars) or differentiated
primary human macrophages (white bars) were challenged with a variety
of unopsonized pathogenic fungi (C. neoformans, Cn; C. gattii. Cg;
Candida albicans, Ca) or LPS, and subsequent supernatants were analyzed
by ELISA, as described in Materials and Methods. Results are expressed
as the mean 6 SD of at least three independent experiments. *p , 0.05.
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show up to 35% similarity with mammalian C-type lectins and can
bind to several PAMPs, including LPS, lipoteichoic acid, and
b-glucan and are inducible when the host is exposed to microbial
challenge or ligands and the mechanisms for uptake of pathogenic
microbes by G. mellonella hemocytes are similar to that of human
neutrophils (62).
Two key reports have shown that there are at least three scav-
enger receptors involved in the recognition of different serotypes of
Cryptococcus neoformans, namely the homologous genes from
the nematode Caenorhabditis elegans, CED-1 and C03F11.3, as
well as the mouse MARCO scavenger receptors (37, 63). Inter-
estingly, knocking out MARCO gene from mice did not abolish
uptake of C. neoformans by lung-resident mononuclear phago-
cytes (37), suggesting a role or roles for the extent and distribution
of multiple receptors and ligands on the surface of both host cell
and yeast.
Finally, we demonstrate that entry of Cryptococcus does not
affect NF-kB nuclear translocation and its subsequent TNF-a
release in the Dectin-1/Syk/NF-kB signaling axis—both in J774.
A1 mouse macrophages and in primary human macrophages.
Although it is known that Dectin-1 coupling to Syk leads to
downstream activation of NF-kB, which coordinates the tran-
scription of innate response genes, including expression of
proinflammatory cytokines such as TNF-a (64–66), this appears
not to be the case for cryptococcal uptake.
In conclusion, we propose that unopsonized Cryptococci are
recognized and engulfed via mannose receptor- or dectin-based
recognition in vitro depending on the activation state of the host
cells. The absence of an associated proinflammatory cascade allows
the yeast to exploit this intracellular niche for rapid disease es-
tablishment.
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